SAN FRANCISCO (August 2, 2018) – JUUL Labs issued a statement today from its Chief Executive Officer, Kevin Burns, on the Company’s submission to the U.S. Food and Drug Administration (FDA) regarding the Advance Notice of Proposed Rulemaking (ANPRM): Regulation of Flavors in Tobacco Products issued on March 21, 2018. JUUL Labs submitted its comments to FDA on July 16, 2018.
“Smoking is still the leading cause of preventable death worldwide, with more than 480,000 deaths in the United States each year. Our mission is to eliminate cigarette smoking in the world by providing adult smokers with a true alternative to cigarettes. We believe flavors play an important role in helping adult smokers switch to vapor technology, which offers great potential.
“We fully support FDA’s efforts to curb underage use of tobacco products, and we believe restricting access to flavors will negatively impact current adult smokers in their journey to switch from combustible cigarettes. Appropriate flavors help adult smokers who do not want to be reminded of the tobacco-taste of a cigarette. We encourage FDA to allow for further scientific exploration on the role flavors play in helping adult smokers transition away from combustible cigarettes.
“As JUUL Labs works to support adult smokers in their efforts to switch, we also remain steadfast in our commitment to preventing underage use of vapor products. Both goals can be achieved through reasonable regulation to restrict advertising and naming of flavors such as cotton candy and gummy bear that are directed at children. We look forward to continuing to engage with FDA, policymakers, and community leaders on helping to reduce cigarette use while protecting young people.”
To read JUUL Labs’ detailed comments on the ANPRM on flavors, please click here.
About JUUL Labs
JUUL Labs is a technology company dedicated to eliminating cigarettes by offering existing adult smokers a true alternative to combustible cigarettes. The company’s research shows that more than one million smokers have already switched to JUUL, and we are working to enable millions more to switch in the coming years through technological innovations.
Media Contact: press@juul.com
October 2, 2024
On September 26th, Juul Labs’ Chairman & Chief Executive Officer, K.C. Crosthwaite, delivered the keynote address at the 2024 Global Tobacco & Nicotine Forum,…
July 29, 2024
Juul Labs announced today the settlement with a group of noteholders that confirms the conversion of the convertible notes to equity, and provides an…
June 6, 2024
Today, the FDA rescinded its June 2022 Marketing Denial Orders (MDOs) for the JUUL System and placed our applications back into scientific review. We appreciate the FDA’s decision and now look forward to re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization for JUUL products.